1-20 of 32
polycystic ovary syndrome
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study

Balachandran Kumarendran, Michael W. O'Reilly, Anuradhaa Subramanian, Dana Šumilo, Konstantinos Toulis, Krishna M. Gokhale, Chandrika N. Wijeratne, Arri Coomarasamy, Abd A. Tahrani, Laurent Azoulay, Wiebke Arlt, Krishnarajah Nirantharakumar
Journal: Diabetes Care
Diabetes Care 2021;44(12):2758–2766
https://doi.org/10.2337/dc21-0437
Published: 15 October 2021
View article titled, Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study
Open the PDF for Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study in another window
Journal Articles

The Risks of Polycystic Ovary Syndrome and Diabetes Vary by Ethnic Subgroup Among Young Asian Women

Lynn Guo, Nancy P. Gordon, Malini Chandra, Olumayowa Dayo, Joan C. Lo
Journal: Diabetes Care
Diabetes Care 2021;44(6):e129–e130
https://doi.org/10.2337/dc21-0373
Published: 18 June 2021
View article titled, The Risks of Polycystic Ovary Syndrome and Diabetes Vary by Ethnic Subgroup Among Young Asian Women
Open the PDF for The Risks of Polycystic Ovary Syndrome and Diabetes Vary by Ethnic Subgroup Among Young Asian Women in another window
Journal Articles

The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome

Nadira S. Kakoly, Arul Earnest, Helena J. Teede, Lisa J. Moran, Anju E. Joham
Journal: Diabetes Care
Diabetes Care 2019;42(4):560–567
https://doi.org/10.2337/dc18-1738
Published: 31 January 2019
View article titled, The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome
Open the PDF for The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome in another window
Includes: Supplementary data
Journal Articles

Type 1 Diabetes and Polycystic Ovary Syndrome: Systematic Review and Meta-analysis

Héctor F. Escobar-Morreale, M. Belén Roldán-Martín
Journal: Diabetes Care
Diabetes Care 2016;39(4):639–648
https://doi.org/10.2337/dc15-2577
Published: 15 March 2016
View article titled, Type 1 Diabetes and Polycystic Ovary Syndrome: Systematic Review and Meta-analysis
Open the PDF for Type 1 Diabetes and Polycystic Ovary Syndrome: Systematic Review and Meta-analysis in another window
Includes: Supplementary data
Journal Articles

How Metformin Acts in PCOS Pregnant Women: Insights into insulin secretion and peripheral action at each trimester of gestation

Daniela Romualdi, PHD, Simona De Cicco, MD, Donatella Gagliano, MD, Matteo Busacca, MD, Giuseppe Campagna, MD, Antonio Lanzone, MD, Maurizio Guido, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(6):1477–1482
https://doi.org/10.2337/dc12-2071
Published: 15 May 2013
View article titled, How Metformin Acts in PCOS Pregnant Women: <subtitle>Insights into insulin secretion and peripheral action at each trimester of gestation</subtitle>
Open the PDF for How Metformin Acts in PCOS Pregnant Women: <subtitle>Insights into insulin secretion and peripheral action at each trimester of gestation</subtitle> in another window
Journal Articles

Zinc-α2-Glycoprotein Is Associated With Insulin Resistance in Humans and Is Regulated by Hyperglycemia, Hyperinsulinemia, or Liraglutide Administration: Cross-sectional and interventional studies in normal subjects, insulin-resistant subjects, and subjects with newly diagnosed diabetes

Mengliu Yang, MD, Rui Liu, PHD, Shu Li, MD, Yu Luo, MD, Yali Zhang, MD, Lili Zhang, PHD, Dongfang Liu, PHD, Yaxu Wang, PHD, Zhengai Xiong, PHD, Guenther Boden, MD, Shirong Chen, PHD, Ling Li, MS, Gangyi Yang, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(5):1074–1082
https://doi.org/10.2337/dc12-0940
Published: 13 April 2013
View article titled, Zinc-α<sub>2</sub>-Glycoprotein Is Associated With Insulin Resistance in Humans and Is Regulated by Hyperglycemia, Hyperinsulinemia, or Liraglutide Administration: <subtitle>Cross-sectional and interventional studies in normal subjects, insulin-resistant subjects, and subjects with newly diagnosed diabetes</subtitle>
Open the PDF for Zinc-α<sub>2</sub>-Glycoprotein Is Associated With Insulin Resistance in Humans and Is Regulated by Hyperglycemia, Hyperinsulinemia, or Liraglutide Administration: <subtitle>Cross-sectional and interventional studies in normal subjects, insulin-resistant subjects, and subjects with newly diagnosed diabetes</subtitle> in another window
Includes: Supplementary data
Journal Articles

Association Between Fasting Blood Glucose and Carotid Intima-Media Thickness of Polycystic Ovary Syndrome Patients With Normal Glucose Tolerance

Kuk Hui Son, MD, PHD, Nam Kyoo Lim, PHD, Hye Won Chung, MD, PHD, Kyungah Jeong, MD, PHD, Wook Bum Pyun, MD, PHD, Ji Young Lee, MD, PHD, Min Ju Kim, MS, Hyun-Young Park, MD, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(5):e66–e67
https://doi.org/10.2337/dc12-1924
Published: 13 April 2013
View article titled, Association Between Fasting Blood Glucose and Carotid Intima-Media Thickness of Polycystic Ovary Syndrome Patients With Normal Glucose Tolerance
Open the PDF for Association Between Fasting Blood Glucose and Carotid Intima-Media Thickness of Polycystic Ovary Syndrome Patients With Normal Glucose Tolerance in another window
Journal Articles

Can a Dietary Supplement Prevent Gestational Diabetes Mellitus?

Donald R. Coustan, MD
Journal: Diabetes Care
Diabetes Care 2013;36(4):777–779
https://doi.org/10.2337/dc12-2505
Published: 14 March 2013
View article titled, Can a Dietary Supplement Prevent Gestational Diabetes Mellitus?
Open the PDF for Can a Dietary Supplement Prevent Gestational Diabetes Mellitus? in another window
Journal Articles

The Risk of a Persistent Glucose Metabolism Impairment After Gestational Diabetes Mellitus Is Increased in Patients With Polycystic Ovary Syndrome

Stefano Palomba, MD, Angela Falbo, MD, Tiziana Russo, MD, Laura Rivoli, MD, Marcello Orio, MD, Andrea Gregorio Cosco, MD, Raffaella Vero, MD, Carmelo Capula, MD, Achille Tolino, MD, Fulvio Zullo, MD, Annamaria Colao, MD, Francesco Orio, MD
Journal: Diabetes Care
Diabetes Care 2012;35(4):861–867
https://doi.org/10.2337/dc11-1971
Published: 13 March 2012
View article titled, The Risk of a Persistent Glucose Metabolism Impairment After Gestational Diabetes Mellitus Is Increased in Patients With Polycystic Ovary Syndrome
Open the PDF for The Risk of a Persistent Glucose Metabolism Impairment After Gestational Diabetes Mellitus Is Increased in Patients With Polycystic Ovary Syndrome in another window
Includes: Supplementary data
Journal Articles

First Evidence of Genetic Association Between AKT2 and Polycystic Ovary Syndrome

Mark O. Goodarzi, MD, PHD, Michelle R. Jones, BSC, Yii-Der I. Chen, PHD, Ricardo Azziz, MD, MBA, MPH
Journal: Diabetes Care
Diabetes Care 2008;31(12):2284–2287
https://doi.org/10.2337/dc08-0532
Published: 01 December 2008
View article titled, First Evidence of Genetic Association Between <em>AKT2</em> and Polycystic Ovary Syndrome
Open the PDF for First Evidence of Genetic Association Between <em>AKT2</em> and Polycystic Ovary Syndrome in another window
Includes: Supplementary data
Journal Articles

Retinol-Binding Protein 4 and Insulin Resistance in Polycystic Ovary Syndrome

Samantha K. Hutchison, MBBS, Cheryce Harrison, BBNSC, Nigel Stepto, PHD, Caroline Meyer, PHD, Helena J. Teede, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(7):1427–1432
https://doi.org/10.2337/dc07-2265
Published: 01 July 2008
View article titled, Retinol-Binding Protein 4 and Insulin Resistance in Polycystic Ovary Syndrome
Open the PDF for Retinol-Binding Protein 4 and Insulin Resistance in Polycystic Ovary Syndrome in another window
Journal Articles

Metabolic Phenotype in the Brothers of Women with Polycystic Ovary Syndrome

Susan Sam, MD, Andrea D. Coviello, MD, Yeon-Ah Sung, MD, Richard S. Legro, MD, Andrea Dunaif, MD
Journal: Diabetes Care
Diabetes Care 2008;31(6):1237–1241
https://doi.org/10.2337/dc07-2190
Published: 01 June 2008
View article titled, Metabolic Phenotype in the Brothers of Women with Polycystic Ovary Syndrome
Open the PDF for Metabolic Phenotype in the Brothers of Women with Polycystic Ovary Syndrome in another window
Journal Articles

Insulin Resistance Is Associated With Decreased Circulating Mannan-Binding Lectin Concentrations in Women With Polycystic Ovary Syndrome

Irina Kowalska, MD, Jose Manuel Fernandez-Real, MD, Marek Straczkowski, MD, Agnieszka Kozlowska, MD, Agnieszka Adamska, MD, Francisco Ortega, MD, Agnieszka Nikolajuk, PHD, Monika Karczewska-Kupczewska, MD, Slawomir Wolczynski, MD, Maria Gorska, MD
Journal: Diabetes Care
Diabetes Care 2008;31(4):e20
https://doi.org/10.2337/dc07-1872
Published: 01 April 2008
View article titled, Insulin Resistance Is Associated With Decreased Circulating Mannan-Binding Lectin Concentrations in Women With Polycystic Ovary Syndrome
Open the PDF for Insulin Resistance Is Associated With Decreased Circulating Mannan-Binding Lectin Concentrations in Women With Polycystic Ovary Syndrome in another window
Journal Articles

Soluble CD36 and Risk Markers of Insulin Resistance and Atherosclerosis Are Elevated in Polycystic Ovary Syndrome and Significantly Reduced During Pioglitazone Treatment

Dorte Glintborg, MD, PHD, Kurt Højlund, MD, PHD, Marianne Andersen, MD, PHD, Jan Erik Henriksen, MD, PHD, Henning Beck-Nielsen, MD, DMSC, Aase Handberg, MD, DMSC
Journal: Diabetes Care
Diabetes Care 2008;31(2):328–334
https://doi.org/10.2337/dc07-1424
Published: 01 February 2008
View article titled, Soluble CD36 and Risk Markers of Insulin Resistance and Atherosclerosis Are Elevated in Polycystic Ovary Syndrome and Significantly Reduced During Pioglitazone Treatment
Open the PDF for Soluble CD36 and Risk Markers of Insulin Resistance and Atherosclerosis Are Elevated in Polycystic Ovary Syndrome and Significantly Reduced During Pioglitazone Treatment in another window
Journal Articles

Increased Body Iron Stores of Obese Women With Polycystic Ovary Syndrome Are a Consequence of Insulin Resistance and Hyperinsulinism and Are Not a Result of Reduced Menstrual Losses

Manuel Luque-Ramírez, MD, Francisco Álvarez-Blasco, MD, José I. Botella-Carretero, MD, PHD, Raul Sanchón, MD, José L. San Millán, PHD, Héctor F. Escobar-Morreale, MD, PHD
Journal: Diabetes Care
Diabetes Care 2007;30(9):2309–2313
https://doi.org/10.2337/dc07-0642
Published: 01 September 2007
View article titled, Increased Body Iron Stores of Obese Women With Polycystic Ovary Syndrome Are a Consequence of Insulin Resistance and Hyperinsulinism and Are Not a Result of Reduced Menstrual Losses
Open the PDF for Increased Body Iron Stores of Obese Women With Polycystic Ovary Syndrome Are a Consequence of Insulin Resistance and Hyperinsulinism and Are Not a Result of Reduced Menstrual Losses in another window
Journal Articles

Gut Hormones, Obesity, Polycystic Ovarian Syndrome, Malignancy, and Lipodystrophy Syndromes

Zachary T. Bloomgarden, MD
Journal: Diabetes Care
Diabetes Care 2007;30(7):1934–1939
https://doi.org/10.2337/dc07-zb07
Published: 01 July 2007
View article titled, Gut Hormones, Obesity, Polycystic Ovarian Syndrome, Malignancy, and Lipodystrophy Syndromes
Open the PDF for Gut Hormones, Obesity, Polycystic Ovarian Syndrome, Malignancy, and Lipodystrophy Syndromes in another window
Journal Articles

Endothelial Function Varies According to Insulin Resistance Disease Type

Joshua A. Beckman, MD, Allison B. Goldfine, MD, Andrea Dunaif, MD, Marie Gerhard-Herman, MD, Mark A. Creager, MD
Journal: Diabetes Care
Diabetes Care 2007;30(5):1226–1232
https://doi.org/10.2337/dc06-2142
Published: 01 May 2007
View article titled, Endothelial Function Varies According to Insulin Resistance Disease Type
Open the PDF for Endothelial Function Varies According to Insulin Resistance Disease Type in another window
Journal Articles

Effects of Medical Therapy on Insulin Resistance and the Cardiovascular System in Polycystic Ovary Syndrome

Caroline Meyer, PHD, Barry P. McGrath, MD, Helena Jane Teede, PHD
Journal: Diabetes Care
Diabetes Care 2007;30(3):471–478
https://doi.org/10.2337/dc06-0618
Published: 01 March 2007
View article titled, Effects of Medical Therapy on Insulin Resistance and the Cardiovascular System in Polycystic Ovary Syndrome
Open the PDF for Effects of Medical Therapy on Insulin Resistance and the Cardiovascular System in Polycystic Ovary Syndrome in another window
Journal Articles

Mutations in the Hereditary Hemochromatosis Gene Are Not Associated With the Increased Body Iron Stores Observed in Overweight and Obese Women With Polycystic Ovary Syndrome

José I. Botella-Carretero, MD, PHD, Manuel Luque-Ramírez, MD, Francisco Álvarez-Blasco, MD, José L. San Millán, PHD, Héctor F. Escobar-Morreale, MD, PHD
Journal: Diabetes Care
Diabetes Care 2006;29(11):2556
https://doi.org/10.2337/dc06-1655
Published: 01 November 2006
View article titled, Mutations in the Hereditary Hemochromatosis Gene Are Not Associated With the Increased Body Iron Stores Observed in Overweight and Obese Women With Polycystic Ovary Syndrome
Open the PDF for Mutations in the Hereditary Hemochromatosis Gene Are Not Associated With the Increased Body Iron Stores Observed in Overweight and Obese Women With Polycystic Ovary Syndrome in another window
Journal Articles

Ovarian Stockpiling in Polycystic Ovary Syndrome, Infertility, and the Combined Use of Rosiglitazone and Metformin

Tarik A. Elhadd, MD, Tarek Fiad, MD, Lorna Meer, MD
Journal: Diabetes Care
Diabetes Care 2006;29(10):2330–2331
https://doi.org/10.2337/dc06-1114
Published: 01 October 2006
View article titled, Ovarian Stockpiling in Polycystic Ovary Syndrome, Infertility, and the Combined Use of Rosiglitazone and Metformin
Open the PDF for Ovarian Stockpiling in Polycystic Ovary Syndrome, Infertility, and the Combined Use of Rosiglitazone and Metformin in another window